AONC: AI 评分 50/100 — AI 分析 (4月 2026)

American Oncology Network, Inc. provides oncology services in the United States, including laboratory, pathology, pharmacy, and care management support. The company operates in the medical care facilities sector, focusing on comprehensive cancer care solutions.

Key Facts: AI Score: 50/100 Sector: Healthcare

公司概况

概要：

American Oncology Network, Inc. delivers comprehensive oncology services, including lab, pathology, pharmacy, and care management. Operating within the U.S. medical care facilities sector, AONC focuses on integrated cancer care solutions, facing competition from established healthcare providers and evolving market dynamics.

AONC是做什么的？

American Oncology Network, Inc. (AONC) was founded in 2017 and is headquartered in Fort Myers, Florida. The company operates in the medical care facilities sector, providing a range of oncology services through its subsidiaries across the United States. AONC’s core offerings include laboratory services for routine and specialized testing, in-house professional and technical pathology services delivering timely reports, and in-house specialty pharmacy services that offer patient education, financial assistance, and round-the-clock patient support. Additionally, AONC provides care management support services, including nutrition guidance, to enhance patient outcomes. By integrating these services, AONC aims to deliver comprehensive and coordinated cancer care to patients, improving their overall experience and treatment efficacy. The company focuses on partnering with community oncology practices, providing them with resources and expertise to enhance their service offerings and operational efficiency. AONC's business model emphasizes a patient-centric approach, ensuring access to advanced treatments and personalized care plans. The company's growth strategy involves expanding its network of affiliated practices and enhancing its service capabilities to meet the evolving needs of cancer patients.

AONC的投资论点是什么？

American Oncology Network, Inc. presents a mixed investment case. AONC's integrated oncology service model, including lab, pathology, and pharmacy services, aims to improve patient care and streamline operations for affiliated practices. However, with a high P/E ratio of 655.43 and a near-zero profit margin, the company's valuation appears stretched. The company's beta of 0.76 suggests lower volatility compared to the market. Growth catalysts include expanding its network of affiliated practices and enhancing service offerings. Potential risks include increasing competition in the oncology services market and regulatory changes affecting healthcare providers. Investors should closely monitor AONC's ability to improve profitability and execute its growth strategy effectively.

AONC在哪个行业运营？

American Oncology Network, Inc. operates within the medical care facilities sector, which is experiencing growth due to the increasing prevalence of cancer and advancements in treatment options. The market is competitive, with established players and smaller specialized providers. Trends include a shift towards personalized medicine, integrated care models, and the adoption of advanced technologies. AONC's focus on providing comprehensive oncology services positions it to capitalize on these trends, but it faces competition from larger healthcare systems and other oncology networks. The industry is also subject to regulatory changes and reimbursement pressures, which can impact profitability and growth.

Medical - Care Facilities

Healthcare

AONC有哪些增长机遇？

Expanding the network of affiliated oncology practices represents a significant growth opportunity for AONC. By partnering with more community-based practices, AONC can increase its patient reach and service volume. The market for oncology services is expanding, driven by an aging population and advancements in cancer treatment. AONC can leverage its integrated service model to attract new practices and enhance its market presence. This expansion could lead to increased revenue and improved economies of scale, with a potential timeline of 2-3 years to realize significant gains.
Enhancing in-house specialty pharmacy services presents another growth avenue. By offering patient education, financial assistance, and 24/7 support, AONC can improve patient adherence and outcomes. The specialty pharmacy market is growing rapidly, driven by the increasing use of targeted therapies and personalized medicine. AONC can capitalize on this trend by expanding its pharmacy capabilities and offering specialized services to its patients. This enhancement could lead to increased revenue and improved patient satisfaction, with a potential timeline of 1-2 years to implement fully.
Developing and expanding care management support services, including nutrition guidance, can improve patient outcomes and reduce healthcare costs. By providing comprehensive care management, AONC can enhance patient adherence to treatment plans and prevent complications. The market for care management services is growing, driven by the increasing focus on value-based care and the need to improve patient outcomes. AONC can leverage its expertise in oncology care to develop and implement effective care management programs. This development could lead to improved patient outcomes and reduced healthcare costs, with a potential timeline of 2-3 years to realize significant benefits.
Investing in advanced diagnostic technologies and laboratory services can enhance AONC's capabilities and attract more patients. By offering state-of-the-art diagnostic services, AONC can improve the accuracy and timeliness of cancer diagnoses. The market for diagnostic technologies is growing rapidly, driven by advancements in genomics and personalized medicine. AONC can capitalize on this trend by investing in advanced technologies and expanding its laboratory capabilities. This investment could lead to improved patient outcomes and increased revenue, with a potential timeline of 3-5 years to implement fully.
Exploring strategic partnerships with other healthcare providers and organizations can expand AONC's reach and service offerings. By collaborating with hospitals, research institutions, and other healthcare providers, AONC can offer a more comprehensive range of services to its patients. The market for healthcare partnerships is growing, driven by the increasing need for integrated care and the desire to improve patient outcomes. AONC can leverage its expertise in oncology care to forge strategic partnerships and expand its market presence. This collaboration could lead to increased revenue and improved patient satisfaction, with a potential timeline of 2-4 years to realize significant gains.

Market capitalization of $0.35 billion indicates a mid-sized player in the medical care facilities sector.
P/E ratio of 655.43 suggests the stock may be overvalued relative to its earnings.
Gross margin of 8.2% indicates relatively low profitability in its core operations.
Beta of 0.76 suggests the stock is less volatile than the overall market.
The company does not offer a dividend, which may deter income-focused investors.

AONC提供哪些产品和服务？

Provides laboratory services for routine and specialized testing.
Offers in-house professional and technical pathology services.
Delivers complete, accurate, and timely pathology reports.
Provides in-house specialty pharmacy services.
Offers patient education and financial assistance.
Provides 24/7 patient assistance through its pharmacy services.
Offers care management support services, including nutrition guidance.

AONC如何赚钱？

Generates revenue through providing oncology services, including laboratory, pathology, and pharmacy services.
Partners with community oncology practices, providing them with resources and expertise.
Focuses on integrating services to deliver comprehensive and coordinated cancer care.

Cancer patients seeking treatment and care.
Community oncology practices affiliated with the network.
Healthcare providers and organizations seeking partnerships.

Integrated service model providing comprehensive oncology care.
Network of affiliated community oncology practices.
In-house specialty pharmacy services offering patient support and education.

什么因素可能推动AONC股价上涨？

Ongoing: Expansion of the network of affiliated oncology practices, increasing patient reach and service volume.
Ongoing: Enhancement of in-house specialty pharmacy services, improving patient adherence and outcomes.
Ongoing: Development and expansion of care management support services, enhancing patient outcomes and reducing healthcare costs.
Upcoming: Potential partnerships with other healthcare providers and organizations, expanding service offerings and market reach.
Upcoming: Investment in advanced diagnostic technologies and laboratory services, improving cancer diagnoses and treatment.

AONC的主要风险是什么？

Ongoing: Increasing competition in the oncology services market, potentially impacting market share and profitability.
Ongoing: Regulatory changes affecting healthcare providers, potentially increasing compliance costs and operational challenges.
Ongoing: Reimbursement pressures from insurance companies, potentially reducing revenue and profitability.
Potential: Economic downturn impacting patient access to care, potentially reducing patient volume and revenue.
Potential: Limited liquidity in the OTC market, making it difficult to buy or sell shares at desired prices.

AONC的核心优势是什么？

Integrated service model offering comprehensive oncology care.
Network of affiliated community oncology practices.
In-house specialty pharmacy services providing patient support.
Care management support services including nutrition guidance.

AONC的劣势是什么？

High P/E ratio suggesting overvaluation.
Low gross margin indicating profitability challenges.
Dependence on affiliated practices for patient volume.
Limited geographic diversification.

AONC有哪些机遇？

Expanding the network of affiliated oncology practices.
Enhancing in-house specialty pharmacy services.
Developing and expanding care management support services.
Investing in advanced diagnostic technologies and laboratory services.

AONC面临哪些威胁？

Increasing competition in the oncology services market.
Regulatory changes affecting healthcare providers.
Reimbursement pressures from insurance companies.
Economic downturn impacting patient access to care.

AONC的竞争对手是谁？

Brookfield Corporation — Diversified asset manager with healthcare investments. — (BHCCF)
DermTech, Inc. — Focuses on dermatological cancer diagnostics. — (DMTRF)
EVO Payments, Inc. — Payment technology and services provider. — (EVGRF)
Hansa Biopharma — Develops enzyme therapies for rare immunological conditions. — (HNSBF)
Mayo Clinic — Non-profit academic medical center. — (MAYNF)

Key Metrics

MoonshotScore: 50/100

Company Profile

CEO: Todd Schonherz
Headquarters: Fort Myers, US
Employees: 1,914
Founded: 2021

AI Insight

AI analysis pending for AONC

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does American Oncology Network, Inc. do?

American Oncology Network, Inc. (AONC) provides comprehensive oncology services in the United States through its subsidiaries. These services include laboratory testing, pathology services, specialty pharmacy services with patient education and financial assistance, and care management support like nutrition guidance. AONC partners with community oncology practices, offering resources and expertise to enhance their service offerings and improve patient outcomes. The company focuses on delivering integrated and coordinated cancer care to patients, aiming to improve their overall experience and treatment efficacy. AONC operates within the medical care facilities sector, emphasizing a patient-centric approach.

What do analysts say about AONC stock?

AI analysis is currently pending for AONC. However, based on available financial data, AONC has a market capitalization of $0.35 billion and a high P/E ratio of 655.43, suggesting the stock may be overvalued. The company's gross margin is 8.2%, indicating relatively low profitability. The stock has a beta of 0.76, suggesting it is less volatile than the overall market. Investors should monitor the company's ability to improve profitability and execute its growth strategy effectively. Further analyst coverage is needed for a comprehensive assessment.

What are the main risks for AONC?

American Oncology Network, Inc. faces several risks, including increasing competition in the oncology services market, which could impact market share and profitability. Regulatory changes affecting healthcare providers and reimbursement pressures from insurance companies could also pose challenges. As an OTC-traded stock, AONC faces additional risks related to limited liquidity and regulatory oversight. An economic downturn could impact patient access to care, reducing patient volume and revenue. Investors should carefully consider these risks before investing in AONC.